Topics

Articles

LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.

Eli Lilly Announces New Telehealth, Home Delivery Option for Popular Weight Loss Drug

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

Trade & Channel Strategies 2023: Enabling Holistic Hub and Provider Services

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Trade & Channel Strategies 2023: Aligning Patient Access

Conference keynote offers an industry outlook, including new commercialization challenges.

Trade & Channel Strategies 2023: A Dive into Pharmacy and the Distribution Channel

A study explores how supply and demand impact the value of medication.

How Drug Shortages Affect Drug Pricing in China

Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST

Is Your Serialization Program Complete and Sustainable?

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Nordic Capital Purchases Majority Share in IntegriChain

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle. 

Access Insights 2023: Fight for the Dollar

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.

Commercial Channels